Le Lézard
Classified in: Health, Science and technology
Subject: Merger/Acquisition

Dr. Reddy's Laboratories to Acquire Select Business Divisions of Wockhardt in India


Dr. Reddy's Laboratories Ltd. ("Dr. Reddy's") (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that it has entered into a definitive agreement with Wockhardt Limited to acquire select divisions of its branded generics business in India and a few other international territories of Nepal, Sri Lanka, Bhutan and Maldives for a consideration of Rs.1850 Crores.

The business comprises of a portfolio of 62 brands in multiple therapy areas such as Respiratory, Neurology, VMS, Dermatology, Gastroenterology, Pain and Vaccines, which would transfer to Dr. Reddy's along with related sales and marketing teams; and the manufacturing plant located in Baddi, Himachal Pradesh with all plant employees. The business undertaking is being transferred on a slump sale basis.

G V Prasad, the Co-Chairman and Managing Director of Dr. Reddy's said, "India is an important market for us and this acquisition will help in considerably scaling-up our domestic business. The acquired portfolio shall enhance Dr. Reddy's presence in the high growth therapy areas with market leading brands such as Practin, Zedex, Bro-zedex, Tryptomer and Biovac. We believe the portfolio holds a lot of potential and will get an impetus under Dr. Reddy's. We welcome the team joining as part of the deal to the Dr. Reddy's family."

The transaction is expected to be closed in the first quarter of the financial year 2020-21.

About Dr. Reddy's: Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products ? Dr. Reddy's offers a portfolio of products and services including APIs, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy's operates in markets across the globe. Our major markets include ? USA, India, Russia & CIS countries, and Europe. For more information, log on to: www.drreddys.com

Disclaimer: This press release may include statements of future expectations and other forward-looking statements that are based on the management's current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words "may", "will", "should", "expects", "plans", "intends", "anticipates", "believes", "estimates", "predicts", "potential", or "continue" and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults , currency exchange rates , interest rates , persistency levels and frequency / severity of insured loss events (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganization , including related integration issues.

The company assumes no obligation to update any information contained herein.


These press releases may also interest you

at 12:53
The number of individuals worldwide watching American Jewish Committee (AJC) Advocacy Anywhere programming is growing as the Coronavirus pandemic compels many across the United States and in countries around the world to stay in their homes. The new...

at 12:00
Consistent with her commitment to children's health and education, Bharti Shah, CEO, CTIS, Inc. is joining hands with Children's National Hospital to build the first of its kind pediatric COVID-19 test site in the country for the District of...

at 10:00
Today, in the context of the COVID-19 virus pandemic, many employees have switched to remote work. Because of this, software that they are used to working with at the office is often not available to them. Users often need to batch convert files from...

at 01:40
? Microchip Technology Inc. (MCHP) is happy to report that it has reached an amicable settlement with plaintiffs James Peterson, Paul Pickle, Rick Goerner and Phil Sansone in the Peterson et al. v. Sanghi et al. lawsuit. The terms of the settlement...

28 mar 2020
During this COVID-19 pandemic, the FDA is working around the clock to make sure that Americans have access to safe food and medical products. The agency is continuously examining the global supply chain to identify any concerns and assess the...

28 mar 2020
Zynga : WHAT Today, the global and far-reaching games industry agreed to disseminate key messages from the World Health Organization to help slow the spread of COVID-19. To promote these messages, 18 game industry leaders in the interactive...



News published on 12 february 2020 at 03:00 and distributed by: